Further, our results show that CRISPR/Cas9-based MUC16 knockout cells show decreased tumor-associated carbohydrate antigens (T and Tn) in PDAC cells, which suggests for the decreased lectin binding observed in this study. This evidence concerns the gene MUC16 and neoplasm.